Ginzac, Angeline http://orcid.org/0000-0002-5614-0876
Molnar, Ioana http://orcid.org/0000-0001-5114-2648
Durando, Xavier http://orcid.org/0000-0001-6035-3172
Motte Rouge, Thibault De La
Petit, Thierry http://orcid.org/0000-0001-8368-3174
D’hondt, Véronique http://orcid.org/0000-0001-5238-4032
Campone, Mario
Bonichon-Lamichhane, Nathalie
Venat Bouvet, Laurence
Levy, Christelle
Augereau, Paule
Pistilli, Barbara
Arsene, Olivier
Jouannaud, Christelle
Nguyen, Suzanne
Cayre, Anne
Tixier, Lucie
Mahier Ait Oukhatar, Céline
Nabholtz, Jean-Marc
Penault-Llorca, Frédérique
Mouret-Reynier, Marie-Ange
Funding for this research was provided by:
Roche France (Roche France)
Unicancer (Unicancer)
Article History
Received: 18 October 2023
Accepted: 7 February 2024
First Online: 7 March 2024
Declarations
:
: The NeoTOP study was approved by French regulatory authorities (2014, July 16th) and French ethics committee Comité de Protection des Personnes (CPP) Sud-Est VI (2014, September 11th).
: Informed consent was obtained from all individual participants included in the study.
: All authors reviewed and approved the final manuscript prior to submission. The authors take full responsibility for the scope, direction, and content of the manuscript.